nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—Doxorubicin—NOS2—psoriatic arthritis	0.0154	1	CrCbGaD
Epirubicin—PLA2G4A—Raltitrexed—Methotrexate—psoriatic arthritis	0.011	0.511	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Methylprednisolone—psoriatic arthritis	0.000958	0.0446	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Methylprednisolone—psoriatic arthritis	0.000958	0.0446	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Dexamethasone—psoriatic arthritis	0.000943	0.0439	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Betamethasone—psoriatic arthritis	0.000943	0.0439	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Triamcinolone—psoriatic arthritis	0.000922	0.0429	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Triamcinolone—psoriatic arthritis	0.000922	0.0429	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—psoriatic arthritis	0.000875	0.0407	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—psoriatic arthritis	0.000875	0.0407	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—psoriatic arthritis	0.000854	0.0397	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—psoriatic arthritis	0.000854	0.0397	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—psoriatic arthritis	0.000717	0.0334	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—psoriatic arthritis	0.0007	0.0326	CbGdCrCtD
Epirubicin—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000496	0.000515	CcSEcCtD
Epirubicin—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000496	0.000515	CcSEcCtD
Epirubicin—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000496	0.000515	CcSEcCtD
Epirubicin—Epistaxis—Methotrexate—psoriatic arthritis	0.000495	0.000514	CcSEcCtD
Epirubicin—Paraesthesia—Prednisolone—psoriatic arthritis	0.000495	0.000514	CcSEcCtD
Epirubicin—Tachycardia—Triamcinolone—psoriatic arthritis	0.000495	0.000514	CcSEcCtD
Epirubicin—Mental disorder—Prednisone—psoriatic arthritis	0.000494	0.000513	CcSEcCtD
Epirubicin—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000494	0.000513	CcSEcCtD
Epirubicin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000492	0.00051	CcSEcCtD
Epirubicin—Erythema—Prednisone—psoriatic arthritis	0.000491	0.00051	CcSEcCtD
Epirubicin—Malnutrition—Prednisone—psoriatic arthritis	0.000491	0.00051	CcSEcCtD
Epirubicin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00049	0.000509	CcSEcCtD
Epirubicin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00049	0.000509	CcSEcCtD
Epirubicin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000489	0.000508	CcSEcCtD
Epirubicin—Convulsion—Dexamethasone—psoriatic arthritis	0.000489	0.000507	CcSEcCtD
Epirubicin—Convulsion—Betamethasone—psoriatic arthritis	0.000489	0.000507	CcSEcCtD
Epirubicin—Hypertension—Dexamethasone—psoriatic arthritis	0.000487	0.000505	CcSEcCtD
Epirubicin—Hypertension—Betamethasone—psoriatic arthritis	0.000487	0.000505	CcSEcCtD
Epirubicin—Myalgia—Dexamethasone—psoriatic arthritis	0.00048	0.000498	CcSEcCtD
Epirubicin—Myalgia—Betamethasone—psoriatic arthritis	0.00048	0.000498	CcSEcCtD
Epirubicin—Anxiety—Betamethasone—psoriatic arthritis	0.000478	0.000497	CcSEcCtD
Epirubicin—Anxiety—Dexamethasone—psoriatic arthritis	0.000478	0.000497	CcSEcCtD
Epirubicin—Discomfort—Dexamethasone—psoriatic arthritis	0.000474	0.000492	CcSEcCtD
Epirubicin—Discomfort—Betamethasone—psoriatic arthritis	0.000474	0.000492	CcSEcCtD
Epirubicin—Haemoglobin—Methotrexate—psoriatic arthritis	0.000474	0.000492	CcSEcCtD
Epirubicin—Hypotension—Methylprednisolone—psoriatic arthritis	0.000473	0.000491	CcSEcCtD
Epirubicin—Pain—Prednisolone—psoriatic arthritis	0.000472	0.00049	CcSEcCtD
Epirubicin—Haemorrhage—Methotrexate—psoriatic arthritis	0.000471	0.000489	CcSEcCtD
Epirubicin—Hepatitis—Methotrexate—psoriatic arthritis	0.000471	0.000489	CcSEcCtD
Epirubicin—Pharyngitis—Methotrexate—psoriatic arthritis	0.000468	0.000486	CcSEcCtD
Epirubicin—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000466	0.000483	CcSEcCtD
Epirubicin—Vision blurred—Prednisone—psoriatic arthritis	0.000463	0.000481	CcSEcCtD
Epirubicin—Urethral disorder—Methotrexate—psoriatic arthritis	0.000462	0.00048	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000462	0.00048	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000461	0.000479	CcSEcCtD
Epirubicin—Oedema—Dexamethasone—psoriatic arthritis	0.00046	0.000478	CcSEcCtD
Epirubicin—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00046	0.000478	CcSEcCtD
Epirubicin—Oedema—Betamethasone—psoriatic arthritis	0.00046	0.000478	CcSEcCtD
Epirubicin—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00046	0.000478	CcSEcCtD
Epirubicin—Insomnia—Triamcinolone—psoriatic arthritis	0.000459	0.000476	CcSEcCtD
Epirubicin—Insomnia—Methylprednisolone—psoriatic arthritis	0.000458	0.000475	CcSEcCtD
Epirubicin—Infection—Betamethasone—psoriatic arthritis	0.000457	0.000475	CcSEcCtD
Epirubicin—Infection—Dexamethasone—psoriatic arthritis	0.000457	0.000475	CcSEcCtD
Epirubicin—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000456	0.000473	CcSEcCtD
Epirubicin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000455	0.000473	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000454	0.000472	CcSEcCtD
Epirubicin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000454	0.000472	CcSEcCtD
Epirubicin—Visual impairment—Methotrexate—psoriatic arthritis	0.000454	0.000472	CcSEcCtD
Epirubicin—Anaemia—Prednisone—psoriatic arthritis	0.000454	0.000471	CcSEcCtD
Epirubicin—Shock—Dexamethasone—psoriatic arthritis	0.000453	0.00047	CcSEcCtD
Epirubicin—Shock—Betamethasone—psoriatic arthritis	0.000453	0.00047	CcSEcCtD
Epirubicin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000452	0.000469	CcSEcCtD
Epirubicin—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000451	0.000469	CcSEcCtD
Epirubicin—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000451	0.000469	CcSEcCtD
Epirubicin—Agitation—Prednisone—psoriatic arthritis	0.000451	0.000469	CcSEcCtD
Epirubicin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000451	0.000468	CcSEcCtD
Epirubicin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000451	0.000468	CcSEcCtD
Epirubicin—Tachycardia—Dexamethasone—psoriatic arthritis	0.000449	0.000466	CcSEcCtD
Epirubicin—Tachycardia—Betamethasone—psoriatic arthritis	0.000449	0.000466	CcSEcCtD
Epirubicin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000446	0.000464	CcSEcCtD
Epirubicin—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000446	0.000463	CcSEcCtD
Epirubicin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000445	0.000463	CcSEcCtD
Epirubicin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000445	0.000462	CcSEcCtD
Epirubicin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000445	0.000462	CcSEcCtD
Epirubicin—Malaise—Prednisone—psoriatic arthritis	0.000443	0.00046	CcSEcCtD
Epirubicin—Vertigo—Prednisone—psoriatic arthritis	0.000441	0.000458	CcSEcCtD
Epirubicin—Eye disorder—Methotrexate—psoriatic arthritis	0.000441	0.000457	CcSEcCtD
Epirubicin—Syncope—Prednisone—psoriatic arthritis	0.00044	0.000457	CcSEcCtD
Epirubicin—Tinnitus—Methotrexate—psoriatic arthritis	0.00044	0.000456	CcSEcCtD
Epirubicin—Anorexia—Dexamethasone—psoriatic arthritis	0.000439	0.000455	CcSEcCtD
Epirubicin—Anorexia—Betamethasone—psoriatic arthritis	0.000439	0.000455	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—psoriatic arthritis	0.000438	0.000455	CcSEcCtD
Epirubicin—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000438	0.000454	CcSEcCtD
Epirubicin—Fatigue—Triamcinolone—psoriatic arthritis	0.000437	0.000454	CcSEcCtD
Epirubicin—Fatigue—Methylprednisolone—psoriatic arthritis	0.000436	0.000453	CcSEcCtD
Epirubicin—Pain—Triamcinolone—psoriatic arthritis	0.000434	0.00045	CcSEcCtD
Epirubicin—Loss of consciousness—Prednisone—psoriatic arthritis	0.000432	0.000448	CcSEcCtD
Epirubicin—Hypotension—Dexamethasone—psoriatic arthritis	0.00043	0.000446	CcSEcCtD
Epirubicin—Hypotension—Betamethasone—psoriatic arthritis	0.00043	0.000446	CcSEcCtD
Epirubicin—Angiopathy—Methotrexate—psoriatic arthritis	0.000428	0.000444	CcSEcCtD
Epirubicin—Immune system disorder—Methotrexate—psoriatic arthritis	0.000426	0.000442	CcSEcCtD
Epirubicin—Convulsion—Prednisone—psoriatic arthritis	0.000425	0.000442	CcSEcCtD
Epirubicin—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000425	0.000441	CcSEcCtD
Epirubicin—Hypertension—Prednisone—psoriatic arthritis	0.000424	0.00044	CcSEcCtD
Epirubicin—Chills—Methotrexate—psoriatic arthritis	0.000423	0.000439	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000419	0.000435	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000419	0.000435	CcSEcCtD
Epirubicin—Myalgia—Prednisone—psoriatic arthritis	0.000418	0.000434	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—psoriatic arthritis	0.000418	0.000434	CcSEcCtD
Epirubicin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000418	0.000434	CcSEcCtD
Epirubicin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000417	0.000433	CcSEcCtD
Epirubicin—Anxiety—Prednisone—psoriatic arthritis	0.000417	0.000433	CcSEcCtD
Epirubicin—Alopecia—Methotrexate—psoriatic arthritis	0.000417	0.000433	CcSEcCtD
Epirubicin—Insomnia—Dexamethasone—psoriatic arthritis	0.000416	0.000432	CcSEcCtD
Epirubicin—Insomnia—Betamethasone—psoriatic arthritis	0.000416	0.000432	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000415	0.000431	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000414	0.00043	CcSEcCtD
Epirubicin—Paraesthesia—Betamethasone—psoriatic arthritis	0.000413	0.000429	CcSEcCtD
Epirubicin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000413	0.000429	CcSEcCtD
Epirubicin—Discomfort—Prednisone—psoriatic arthritis	0.000413	0.000429	CcSEcCtD
Epirubicin—Mental disorder—Methotrexate—psoriatic arthritis	0.000413	0.000429	CcSEcCtD
Epirubicin—Erythema—Methotrexate—psoriatic arthritis	0.00041	0.000426	CcSEcCtD
Epirubicin—Malnutrition—Methotrexate—psoriatic arthritis	0.00041	0.000426	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000406	0.000422	CcSEcCtD
Epirubicin—Dyspepsia—Betamethasone—psoriatic arthritis	0.000405	0.000421	CcSEcCtD
Epirubicin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000405	0.000421	CcSEcCtD
Epirubicin—Urticaria—Triamcinolone—psoriatic arthritis	0.000403	0.000418	CcSEcCtD
Epirubicin—Urticaria—Methylprednisolone—psoriatic arthritis	0.000402	0.000417	CcSEcCtD
Epirubicin—Dysgeusia—Methotrexate—psoriatic arthritis	0.000402	0.000417	CcSEcCtD
Epirubicin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000401	0.000416	CcSEcCtD
Epirubicin—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000401	0.000416	CcSEcCtD
Epirubicin—Oedema—Prednisone—psoriatic arthritis	0.000401	0.000416	CcSEcCtD
Epirubicin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.0004	0.000415	CcSEcCtD
Epirubicin—Decreased appetite—Betamethasone—psoriatic arthritis	0.0004	0.000415	CcSEcCtD
Epirubicin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.0004	0.000415	CcSEcCtD
Epirubicin—Infection—Prednisone—psoriatic arthritis	0.000398	0.000413	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000397	0.000413	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000397	0.000413	CcSEcCtD
Epirubicin—Back pain—Methotrexate—psoriatic arthritis	0.000397	0.000412	CcSEcCtD
Epirubicin—Fatigue—Betamethasone—psoriatic arthritis	0.000397	0.000412	CcSEcCtD
Epirubicin—Fatigue—Dexamethasone—psoriatic arthritis	0.000397	0.000412	CcSEcCtD
Epirubicin—Shock—Prednisone—psoriatic arthritis	0.000394	0.000409	CcSEcCtD
Epirubicin—Pain—Betamethasone—psoriatic arthritis	0.000394	0.000409	CcSEcCtD
Epirubicin—Pain—Dexamethasone—psoriatic arthritis	0.000394	0.000409	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—psoriatic arthritis	0.000393	0.000408	CcSEcCtD
Epirubicin—Tachycardia—Prednisone—psoriatic arthritis	0.000391	0.000406	CcSEcCtD
Epirubicin—Skin disorder—Prednisone—psoriatic arthritis	0.000389	0.000404	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000387	0.000402	CcSEcCtD
Epirubicin—Vision blurred—Methotrexate—psoriatic arthritis	0.000387	0.000402	CcSEcCtD
Epirubicin—Anorexia—Prednisone—psoriatic arthritis	0.000382	0.000397	CcSEcCtD
Epirubicin—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000381	0.000395	CcSEcCtD
Epirubicin—Anaemia—Methotrexate—psoriatic arthritis	0.000379	0.000394	CcSEcCtD
Epirubicin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000379	0.000394	CcSEcCtD
Epirubicin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000379	0.000394	CcSEcCtD
Epirubicin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000376	0.000391	CcSEcCtD
Epirubicin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000376	0.000391	CcSEcCtD
Epirubicin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000374	0.000388	CcSEcCtD
Epirubicin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000373	0.000387	CcSEcCtD
Epirubicin—Malaise—Methotrexate—psoriatic arthritis	0.00037	0.000384	CcSEcCtD
Epirubicin—Vertigo—Methotrexate—psoriatic arthritis	0.000369	0.000383	CcSEcCtD
Epirubicin—Leukopenia—Methotrexate—psoriatic arthritis	0.000367	0.000381	CcSEcCtD
Epirubicin—Urticaria—Betamethasone—psoriatic arthritis	0.000366	0.00038	CcSEcCtD
Epirubicin—Urticaria—Dexamethasone—psoriatic arthritis	0.000366	0.00038	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000365	0.000379	CcSEcCtD
Epirubicin—Dizziness—Prednisolone—psoriatic arthritis	0.000365	0.000379	CcSEcCtD
Epirubicin—Asthenia—Triamcinolone—psoriatic arthritis	0.000364	0.000378	CcSEcCtD
Epirubicin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000364	0.000378	CcSEcCtD
Epirubicin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000364	0.000378	CcSEcCtD
Epirubicin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000364	0.000378	CcSEcCtD
Epirubicin—Body temperature increased—Betamethasone—psoriatic arthritis	0.000364	0.000378	CcSEcCtD
Epirubicin—Asthenia—Methylprednisolone—psoriatic arthritis	0.000363	0.000377	CcSEcCtD
Epirubicin—Insomnia—Prednisone—psoriatic arthritis	0.000362	0.000376	CcSEcCtD
Epirubicin—Paraesthesia—Prednisone—psoriatic arthritis	0.00036	0.000374	CcSEcCtD
Epirubicin—Pruritus—Triamcinolone—psoriatic arthritis	0.000359	0.000373	CcSEcCtD
Epirubicin—Cough—Methotrexate—psoriatic arthritis	0.000358	0.000372	CcSEcCtD
Epirubicin—Pruritus—Methylprednisolone—psoriatic arthritis	0.000358	0.000372	CcSEcCtD
Epirubicin—Convulsion—Methotrexate—psoriatic arthritis	0.000356	0.000369	CcSEcCtD
Epirubicin—Dyspepsia—Prednisone—psoriatic arthritis	0.000353	0.000366	CcSEcCtD
Epirubicin—Arthralgia—Methotrexate—psoriatic arthritis	0.000349	0.000363	CcSEcCtD
Epirubicin—Chest pain—Methotrexate—psoriatic arthritis	0.000349	0.000363	CcSEcCtD
Epirubicin—Myalgia—Methotrexate—psoriatic arthritis	0.000349	0.000363	CcSEcCtD
Epirubicin—Decreased appetite—Prednisone—psoriatic arthritis	0.000348	0.000362	CcSEcCtD
Epirubicin—Rash—Prednisolone—psoriatic arthritis	0.000348	0.000361	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—psoriatic arthritis	0.000347	0.000361	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000347	0.00036	CcSEcCtD
Epirubicin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000346	0.000359	CcSEcCtD
Epirubicin—Fatigue—Prednisone—psoriatic arthritis	0.000346	0.000359	CcSEcCtD
Epirubicin—Headache—Prednisolone—psoriatic arthritis	0.000346	0.000359	CcSEcCtD
Epirubicin—Discomfort—Methotrexate—psoriatic arthritis	0.000345	0.000358	CcSEcCtD
Epirubicin—Constipation—Prednisone—psoriatic arthritis	0.000343	0.000356	CcSEcCtD
Epirubicin—Confusional state—Methotrexate—psoriatic arthritis	0.000338	0.000351	CcSEcCtD
Epirubicin—Dizziness—Triamcinolone—psoriatic arthritis	0.000335	0.000348	CcSEcCtD
Epirubicin—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000335	0.000348	CcSEcCtD
Epirubicin—Dizziness—Methylprednisolone—psoriatic arthritis	0.000335	0.000347	CcSEcCtD
Epirubicin—Infection—Methotrexate—psoriatic arthritis	0.000333	0.000345	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisone—psoriatic arthritis	0.00033	0.000343	CcSEcCtD
Epirubicin—Asthenia—Dexamethasone—psoriatic arthritis	0.00033	0.000343	CcSEcCtD
Epirubicin—Asthenia—Betamethasone—psoriatic arthritis	0.00033	0.000343	CcSEcCtD
Epirubicin—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000328	0.000341	CcSEcCtD
Epirubicin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000328	0.00034	CcSEcCtD
Epirubicin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000328	0.00034	CcSEcCtD
Epirubicin—Nausea—Prednisolone—psoriatic arthritis	0.000328	0.00034	CcSEcCtD
Epirubicin—Pruritus—Betamethasone—psoriatic arthritis	0.000326	0.000338	CcSEcCtD
Epirubicin—Pruritus—Dexamethasone—psoriatic arthritis	0.000326	0.000338	CcSEcCtD
Epirubicin—Skin disorder—Methotrexate—psoriatic arthritis	0.000325	0.000338	CcSEcCtD
Epirubicin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000324	0.000336	CcSEcCtD
Epirubicin—Vomiting—Triamcinolone—psoriatic arthritis	0.000322	0.000335	CcSEcCtD
Epirubicin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000322	0.000334	CcSEcCtD
Epirubicin—Rash—Triamcinolone—psoriatic arthritis	0.00032	0.000332	CcSEcCtD
Epirubicin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000319	0.000332	CcSEcCtD
Epirubicin—Anorexia—Methotrexate—psoriatic arthritis	0.000319	0.000331	CcSEcCtD
Epirubicin—Rash—Methylprednisolone—psoriatic arthritis	0.000319	0.000331	CcSEcCtD
Epirubicin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000319	0.000331	CcSEcCtD
Epirubicin—Urticaria—Prednisone—psoriatic arthritis	0.000318	0.000331	CcSEcCtD
Epirubicin—Headache—Triamcinolone—psoriatic arthritis	0.000318	0.00033	CcSEcCtD
Epirubicin—Headache—Methylprednisolone—psoriatic arthritis	0.000317	0.000329	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—psoriatic arthritis	0.000317	0.000329	CcSEcCtD
Epirubicin—Body temperature increased—Prednisone—psoriatic arthritis	0.000317	0.000329	CcSEcCtD
Epirubicin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000315	0.000327	CcSEcCtD
Epirubicin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000315	0.000327	CcSEcCtD
Epirubicin—Hypotension—Methotrexate—psoriatic arthritis	0.000313	0.000325	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000305	0.000317	CcSEcCtD
Epirubicin—Dizziness—Dexamethasone—psoriatic arthritis	0.000304	0.000316	CcSEcCtD
Epirubicin—Dizziness—Betamethasone—psoriatic arthritis	0.000304	0.000316	CcSEcCtD
Epirubicin—Insomnia—Methotrexate—psoriatic arthritis	0.000303	0.000315	CcSEcCtD
Epirubicin—Nausea—Triamcinolone—psoriatic arthritis	0.000301	0.000313	CcSEcCtD
Epirubicin—Paraesthesia—Methotrexate—psoriatic arthritis	0.000301	0.000312	CcSEcCtD
Epirubicin—Nausea—Methylprednisolone—psoriatic arthritis	0.000301	0.000312	CcSEcCtD
Epirubicin—Dyspnoea—Methotrexate—psoriatic arthritis	0.000299	0.00031	CcSEcCtD
Epirubicin—Somnolence—Methotrexate—psoriatic arthritis	0.000298	0.000309	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000295	0.000307	CcSEcCtD
Epirubicin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000295	0.000306	CcSEcCtD
Epirubicin—Vomiting—Dexamethasone—psoriatic arthritis	0.000293	0.000304	CcSEcCtD
Epirubicin—Vomiting—Betamethasone—psoriatic arthritis	0.000293	0.000304	CcSEcCtD
Epirubicin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000291	0.000302	CcSEcCtD
Epirubicin—Rash—Dexamethasone—psoriatic arthritis	0.00029	0.000301	CcSEcCtD
Epirubicin—Rash—Betamethasone—psoriatic arthritis	0.00029	0.000301	CcSEcCtD
Epirubicin—Dermatitis—Betamethasone—psoriatic arthritis	0.00029	0.000301	CcSEcCtD
Epirubicin—Dermatitis—Dexamethasone—psoriatic arthritis	0.00029	0.000301	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000289	0.0003	CcSEcCtD
Epirubicin—Fatigue—Methotrexate—psoriatic arthritis	0.000289	0.0003	CcSEcCtD
Epirubicin—Headache—Betamethasone—psoriatic arthritis	0.000288	0.000299	CcSEcCtD
Epirubicin—Headache—Dexamethasone—psoriatic arthritis	0.000288	0.000299	CcSEcCtD
Epirubicin—Asthenia—Prednisone—psoriatic arthritis	0.000288	0.000299	CcSEcCtD
Epirubicin—Pain—Methotrexate—psoriatic arthritis	0.000286	0.000297	CcSEcCtD
Epirubicin—Pruritus—Prednisone—psoriatic arthritis	0.000284	0.000294	CcSEcCtD
Epirubicin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000276	0.000287	CcSEcCtD
Epirubicin—Diarrhoea—Prednisone—psoriatic arthritis	0.000274	0.000285	CcSEcCtD
Epirubicin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000274	0.000284	CcSEcCtD
Epirubicin—Nausea—Betamethasone—psoriatic arthritis	0.000273	0.000284	CcSEcCtD
Epirubicin—Nausea—Dexamethasone—psoriatic arthritis	0.000273	0.000284	CcSEcCtD
Epirubicin—Urticaria—Methotrexate—psoriatic arthritis	0.000266	0.000276	CcSEcCtD
Epirubicin—Dizziness—Prednisone—psoriatic arthritis	0.000265	0.000275	CcSEcCtD
Epirubicin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000265	0.000275	CcSEcCtD
Epirubicin—Body temperature increased—Methotrexate—psoriatic arthritis	0.000265	0.000275	CcSEcCtD
Epirubicin—Vomiting—Prednisone—psoriatic arthritis	0.000255	0.000265	CcSEcCtD
Epirubicin—Rash—Prednisone—psoriatic arthritis	0.000253	0.000262	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—psoriatic arthritis	0.000252	0.000262	CcSEcCtD
Epirubicin—Headache—Prednisone—psoriatic arthritis	0.000251	0.000261	CcSEcCtD
Epirubicin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000247	0.000256	CcSEcCtD
Epirubicin—Asthenia—Methotrexate—psoriatic arthritis	0.00024	0.00025	CcSEcCtD
Epirubicin—Nausea—Prednisone—psoriatic arthritis	0.000238	0.000247	CcSEcCtD
Epirubicin—Pruritus—Methotrexate—psoriatic arthritis	0.000237	0.000246	CcSEcCtD
Epirubicin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000229	0.000238	CcSEcCtD
Epirubicin—Dizziness—Methotrexate—psoriatic arthritis	0.000221	0.00023	CcSEcCtD
Epirubicin—Vomiting—Methotrexate—psoriatic arthritis	0.000213	0.000221	CcSEcCtD
Epirubicin—Rash—Methotrexate—psoriatic arthritis	0.000211	0.000219	CcSEcCtD
Epirubicin—Dermatitis—Methotrexate—psoriatic arthritis	0.000211	0.000219	CcSEcCtD
Epirubicin—Headache—Methotrexate—psoriatic arthritis	0.00021	0.000218	CcSEcCtD
Epirubicin—Nausea—Methotrexate—psoriatic arthritis	0.000199	0.000207	CcSEcCtD
